ITOS - iTeos Therapeutics GAAP EPS of $0.03 November, 10 2022 05:21 PM iTeos Therapeutics Inc. iTeos Therapeutics press release ( NASDAQ: ITOS ): Q3 GAAP EPS of $0.03. The company’s cash and cash equivalent position was $752.2 million as of September 30, 2022, as compared to $899.8 million as of September 30, 2021. For further details see: iTeos Therapeutics GAAP EPS of $0.03